Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Forum on Immunopathological Diseases and Therapeutics

ISSN Print: 2151-8017
ISSN Online: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

Buy Issue $576.00 Volume 5, 2014 Issue 3-4

DOI: 10.1615/ForumImmunDisTher.v5.i3-4

Table of Contents:

Preface: Advances in Molecular Targets for Therapeutics in Resistant Cancers
Melchiorre Cervello, Natale D'Alessandro
pages v-vi
DOI: 10.1615/ForumImmunDisTher.2015014075
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC
Maurizio Soresi, Lydia Giannitrapani, Walter Grana, Anna Licata, Giuseppe Montalto
pages 115-136
DOI: 10.1615/ForumImmunDisTher.2015014080
The Role of HSP70 in the Diagnosis of HCC
Lydia Giannitrapani, Gabriele Multhoff
pages 137-143
DOI: 10.1615/ForumImmunDisTher.2015013939
From Targets to Targeted Therapies in Hepatocellular Carcinoma
Melchiorre Cervello, Maria Rita Emma, Giuseppa Augello, Daniele Balasus, Antonina Azzolina, James A. McCubrey, Antonella Cusimano
pages 145-194
DOI: 10.1615/ForumImmunDisTher.2015013982
Druggable Targets in Pancreatic Adenocarcinoma
Stefania Nobili, Renato Tassi, Ida Landini, Gabriele Perrone, Cristina Napoli, Enrico Mini
pages 195-214
DOI: 10.1615/ForumImmunDisTher.2015014118
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors
Natale D'Alessandro, Paola Poma, Manuela Labbozzetta, Nicoletta Vivona, Monica Notarbartolo
pages 215-222
DOI: 10.1615/ForumImmunDisTher.2015013936
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis
Sandra Donnini, Federica Finetti, Erika Terzuoli, Lorenzo Bazzani, Marina Ziche
pages 223-232
DOI: 10.1615/ForumImmunDisTher.2015014095
Targeting Integrins in Cancer
Chiara Pazzagli, Sandra Donnini
pages 233-241
DOI: 10.1615/ForumImmunDisTher.2015013962
VOLUME 5 CONTENTS, 2014
pages 243-245
DOI: 10.1615/ForumImmunDisTher.v5.i3-4.90